Ormond, Kelly E; Bavamian, Sabine; Becherer, Claudia; Currat, Christine; Joerger, Francisca; Geiger, Thomas R; Hiendlmeyer, Elke; Maurer, Julia; Staub, Timo; Vayena, Effy (2024). What are the bottlenecks to health data sharing in Switzerland? An interview study. Swiss medical weekly, 154(1) SMW supporting association 10.57187/s.3538
|
Text
smw-2024-3538.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (282kB) | Preview |
BACKGROUND
While health data sharing for research purposes is strongly supported in principle, it can be challenging to implement in practice. Little is known about the actual bottlenecks to health data sharing in Switzerland.
AIMS OF THE STUDY
This study aimed to assess the obstacles to Swiss health data sharing, including legal, ethical and logistical bottlenecks.
METHODS
We identified 37 key stakeholders in data sharing via the Swiss Personalised Health Network ecosystem, defined as being an expert on sharing sensitive health data for research purposes at a Swiss university hospital (or a Swiss disease cohort) or being a stakeholder in data sharing at a public or private institution that uses such data. We conducted semi-structured interviews, which were transcribed, translated when necessary, and de-identified. The entire research team discussed the transcripts and notes taken during each interview before an inductive coding process occurred.
RESULTS
Eleven semi-structured interviews were conducted (primarily in English) with 17 individuals representing lawyers, data protection officers, ethics committee members, scientists, project managers, bioinformaticians, clinical trials unit members, and biobank stakeholders. Most respondents felt that it was not the actual data transfer that was the bottleneck but rather the processes and systems around it, which were considered time-intensive and confusing. The templates developed by the Swiss Personalised Health Network and the Swiss General Consent process were generally felt to have streamlined processes significantly. However, these logistics and data quality issues remain practical bottlenecks in Swiss health data sharing. Areas of legal uncertainty include privacy laws when sharing data internationally, questions of "who owns the data", inconsistencies created because the Swiss general consent is perceived as being implemented differently across different institutions, and definitions and operationalisation of anonymisation and pseudo-anonymisation. Many participants desired to create a "culture of data sharing" and to recognise that data sharing is a process with many steps, not an event, that requires sustainability efforts and personnel. Some participants also stressed a desire to move away from data sharing and the current privacy focus towards processes that facilitate data access.
CONCLUSIONS
Facilitating a data access culture in Switzerland may require legal clarifications, further education about the process and resources to support data sharing, and further investment in sustainable infrastructureby funders and institutions.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Faculty Institutions > Bern Center for Precision Medicine (BCPM) |
UniBE Contributor: |
Staub, Timo Pekka |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1424-3997 |
Publisher: |
SMW supporting association |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
09 Apr 2024 14:46 |
Last Modified: |
09 Apr 2024 14:55 |
Publisher DOI: |
10.57187/s.3538 |
PubMed ID: |
38579329 |
BORIS DOI: |
10.48350/195706 |
URI: |
https://boris.unibe.ch/id/eprint/195706 |